0001479290-22-000071.txt : 20220513
0001479290-22-000071.hdr.sgml : 20220513
20220513181726
ACCESSION NUMBER: 0001479290-22-000071
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220504
FILED AS OF DATE: 20220513
DATE AS OF CHANGE: 20220513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Russell Angus C.
CENTRAL INDEX KEY: 0001534002
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 22924460
MAIL ADDRESS:
STREET 1: C/O INTERMUNE, INC.
STREET 2: 3280 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1222 DEMONBREUN STREET
STREET 2: SUITE 2000
CITY: NASHVILLE
STATE: TN
ZIP: 37203
BUSINESS PHONE: 6157247755
MAIL ADDRESS:
STREET 1: 1222 DEMONBREUN STREET
STREET 2: SUITE 2000
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4/A
1
wf-form4a_165248019122400.xml
FORM 4/A
X0306
4/A
2022-05-04
2022-05-06
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001534002
Russell Angus C.
C/O REVANCE THERAPEUTICS, INC.
1222 DEMONBREUN STREET, SUITE 2000
NASHVILLE
TN
37203
1
0
0
0
Stock Option (Right to buy)
18.12
2022-05-04
4
A
0
10756
0
A
2032-05-03
Common Stock
10756.0
10756
D
The shares subject to the stock option shall vest on the one year anniversary, May 4, 2023, subject to Mr. Russell's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date. The stock option represents an annual grant pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy.
The original Form 4, filed on May 6, 2022, inadvertently listed the incorrect number of options granted to the Reporting Person on May 4, 2022 due to an administrative error. This Form 4/A is being filed to correct the number of shares underlying the stock option originally reported.
/s/ Dwight Moxie, Attorney-in-Fact
2022-05-13